Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003-2022. [PDF]
Nuwamanya Y+10 more
europepmc +1 more source
Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States. [PDF]
Yi Z, Owusu-Edusei K, Elbasha E.
europepmc +1 more source
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults. [PDF]
Rey-Ares L+6 more
europepmc +1 more source
Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS). [PDF]
Oliveira M+7 more
europepmc +1 more source
PIN17: THE VALUE OF VACCINATING INFANTS AND CHILDREN WITH PNEUMOCOCCAL CONJUGATE VACCINE
MW Ford, ECY Wang
openalex +1 more source
Radiographically confirmed pneumonia in Malawian children and associated pneumococcal carriage after introduction of the 13-valent pneumococcal conjugate vaccine. [PDF]
Mzumara G+13 more
europepmc +1 more source
A Pharmacoeconomic Evaluation of Seven-Valent Pneumococcal Conjugate Vaccine in Spain
F Asensi+7 more
openalex +1 more source
A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015. [PDF]
Yen TA+9 more
europepmc +1 more source